Prognostic stratification for children with hepatoblastoma: The SIOPEL experience

European Journal of Cancer

Volumn 48, Issue 10, 2012, Pages 1543-1549

  Maibach, Rudolf ^a   Roebuck, Derek ^b   Brugieres, Laurence ^c   Capra, Michael ^d   Brock, Penelope ^b   Dall'Igna, Patrizia ^e   Otte, Jean Bernard ^f   De Camargo, Beatriz ^g   Zsiros, Jozsef ^h   Zimmermann, Arthur ⁱ   Aronson, Daniel ^j   Childs, Margaret ^k   Scopinaro, Marcelo ^l   Morland, Bruce ^m   Plaschkes, Jack ⁿ   Czauderna, Piotr ^o   Perilongo, Giorgio ^e  

^a IBCSG Coordinating Center   (Switzerland)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d OUR LADY S CHILDREN S HOSPITAL   (Ireland)

^e Division of Paediatrics Obstetrics and Gynaecology   (Italy)

^f CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^g Estado de São Paulo Octavio Frias de Oliveira   (Brazil)

^h EMMA CHILDREN S HOSPITAL   (Netherlands)

ⁱ Unilabs Mittelland   (Switzerland)

^j RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^k CCLG Data Centre   (United Kingdom)

^l Hospital de Pediatria SAMIC Prof Dr Juan P Garrahan   (Argentina)

^m BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

ⁿ UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^o MEDICAL UNIVERSITY OF GDANSK   (Poland)

more..

Author keywords

Alpha fetoprotein; Clinical trial; Hepatoblastoma; Metastasis; Prognostic factor; Tumour staging

Indexed keywords

CARBOPLATIN; CISPLATIN; DOXORUBICIN;

AGE; ARTICLE; CANCER INVASION; CANCER PROGNOSIS; CELL DIFFERENTIATION; CHILD; EVENT FREE SURVIVAL; FEMALE; HEPATOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; THROMBOCYTE COUNT;

ADOLESCENT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; HEPATOBLASTOMA; HUMANS; INFANT; INFANT, NEWBORN; MALE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK; TIME FACTORS; TREATMENT OUTCOME;

EID: 84862011232     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2011.12.011     Document Type: Article

References (18)

1. G. Perilongo, E. Shafford, and R. Maibach Risk-adapted treatment for childhood hepatoblastoma. Final report of the second study of the International Society of Paediatric Oncology - SIOPEL 2 Eur J Cancer 40 2004 411 421
2. G. Perilongo, R. Maibach, and E. Shafford Cisplatin versus cisplatin plus doxorubicin for standard risk hepatoblastoma N Engl J Med 361 17 2009 1662 1670
3. J. Zsíros, R. Maibach, and E. Shafford Successful treatment of childhood high risk hepatoblastoma with dose intensive multiagent chemotherapy and surgery - final results of the SIOPEL-3HR study of the childhood Liver tumor strategy group J Clin Oncol 28 15 2010 2584 2590
4. J. Brown, G. Perilongo, and E. Shafford Pretreatment prognostic factors for children with hepatoblastoma - results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1 Eur J Cancer 36 11 2000 1418 1425
5. G.A. MacKinlay, and J. Pritchard A common language for childhood liver tumours Pediatr Surg Int 7 1992 325 326
6. J. Pritchard, J. Brown, and E. Shafford Cisplatin, doxorubicin, and delayed surgery for childhood hepatoblastoma: a successful approach - results of the first prospective study of the International Society of Pediatric Oncology J Clin Oncol 18 2000 3819 3828
7. D.C. Aronson, J.M. Schnater, and C.R. Staalman Predictive value of the pretreatment extent of disease system in hepatoblastoma: results from the International Society of Pediatric Oncology Liver Tumor Study Group SIOPEL-1 study J Clin Oncol 23 2005 1245 1252
8. M.H. Malogolowkin, H. Katzenstein, and M.D. Krailo Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma J Clin Oncol 24 18 2006 2879 2884
9. G. Perilongo, J. Brown, and E. Shafford Hepatoblastoma presenting with lung metastases: treatment results of the first cooperative, prospective study of the International Society of Paediatric Oncology on childhood liver tumors Cancer 89 8 2000 1845 1853
10. M. De Ioris, L. Brugieres, and A. Zimmermann Hepatoblastoma with a low serum alpha-fetoprotein level at diagnosis: the SIOPEL group experience Eur J Cancer 44 2008 545 550
11. A.D. Trobaugh-Lotrario, G.E. Tomlinson, and M.J. Finegold Small cell undifferentiated variant of hepatoblastoma: adverse clinical and molecular features similar to rhabdoid tumors Pediatr Blood Cancer 52 3 2009 328 334
12. R.L. Meyers, J.R. Rowland, and M. Krailo Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the Children's Oncology Group Pediatr Blood Cancer 53 2009 1016 1022
13. P. Czauderna, J.B. Otte, and D.C. Aronson Guidelines for surgical treatment of hepatoblastoma in the modern era - recommendations from the Childhood Liver Tumour Strategy Group of the International Society of Paediatric Oncology (SIOPEL) Eur J Cancer 41 2005 1031 1036
14. J.B. Otte, J. Pritchard, and D.C. Aronson Liver Transplantation for Hepatoblastoma: Results From the International Society of Pediatric Oncology (SIOP) Study SIOPEL-1 and Review of the World Experience Pediatr Blood Cancer 42 2004 74 83
15. D. von Schweinitz, H. Hecker, and G. Schmidt-von-Arndt Prognostic factors and staging systems in childhood hepatoblastoma Int J Cancer 74 1997 593 599
16. A. Prokurat, P. Kluge, and A. Kosciesza Transitional liver cell tumors (TLCT) in older children and adolescents: a novel group of aggressive hepatic tumors expressing beta-catenin Med Pediatr Oncol 39 2002 510 518
17. H.M. Katzenstein, W.B. London, and E.C. Douglass Treatment of unresectable and metastatic hepatoblastoma: a pediatric oncology group phase II study J Clin Oncol 20 16 2002 3438 3444
18. J.A. Ortega, E.C. Douglass, and J.H. Feusner Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: a report from the Children's Cancer Group and the Pediatric Oncology Group J Clin Oncol 18 2000 2665 2675